勃林格殷格翰的能倍乐怎么购买？

It has good effects and high safety. It has been approved for marketing in my country in 2014, bringing new and effective options for the treatment of domestic patients with chronic obstructive pulmonary disease. Respimat is a prescription drug and your doctor must be consulted before starting treatment. Respimat should not be used if the patient is allergic to the drug or its ingredients. So, how to buy Boehringer Ingelheim’s Respimat?

Respimat has been on the market in China since 2014, so patients only need to rely on pharmacies to buy Respimat at major domestic pharmacies. In addition, Respimat has been included in Category B of medical insurance, but the reimbursement standards of medical insurance vary from place to place. Compared with the domestic price, it is still relatively expensive. It is understood that the current relatively low price of Respimat is about 170 US dollars per box. Patients in need can buy it abroad or obtain the medicine through domestic professional overseas medical service organizations (such as Medical Companion Travel), and have it shipped directly to their homes, ensuring authenticity.

Boehringer Ingelheim is a pharmaceutical company dedicated to human biopharmaceutical chemistry and animal health products. It is also the world's largest privately held pharmaceutical company. Boehringer Ingelheim's main research areas include: immune and respiratory diseases, cardiovascular and metabolic diseases, central nervous system diseases, and tumors. Boehringer Ingelheim has a complete biopharmaceutical industry chain, from genetic engineering of cells to manufacturing, and commercial production of off-the-shelf medicines for external industrial customers.

Respimat was developed by Boehringer Ingelheim and has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with chronic obstructive pulmonary disease (COPD), making it easier for them to breathe. COPD is a long-term lung disease that causes shortness of breath and coughing. Respimat helps open the airways, making it easier for air to move in and out of the lungs. Normal use of Respimat can also relieve persistent shortness of breath caused by the disease, helping to minimize the impact of the disease on daily life.

It is suitable for the maintenance treatment of chronic obstructive pulmonary disease (COPD, including chronic bronchitis and emphysema) and related dyspnea. It can improve the quality of life of COPD patients and reduce acute exacerbations of COPD.